𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical significance of A, B, H isoantigen deletion of urothelial cells in bladder carcinoma

✍ Scribed by Eric Borgström; Britta Wahren

Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
633 KB
Volume
58
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of cell cycle proteins in T1a
Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression
✍ Paulette Mhawech; Vincent Greloz; Chantal Oppikofer; Idliko Szalay-Quinodoz; Fra 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract ## BACKGROUND Cell cycle proteins are important markers in predicting tumor behavior in urothelial carcinoma of the bladder. The objectives of this study were 1) to determine the expression levels of some of those markers in a series of patients with bladder carcinoma, 2) to define the

Cloning of the human uroplakin 1B cDNA a
Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissue
✍ Jennie L. Finch; John Miller; James O. Aspinall; Prudence A. Cowled 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB 👁 2 views

The human uroplakin 1B (UPK1B) gene codes for a structural protein which is a terminal differentiation component of the asymmetric unit membrane on the apical surface of the mammalian bladder. UPK1B is a member of the tetraspan family of proteins, many of which have de-regulated patterns of expressi

A-FABP, a candidate progression marker o
A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells
✍ Guillaume Boiteux; Isabelle Lascombe; Emmanuelle Roche; Marie-Laure Plissonnier; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 398 KB 👁 1 views

## Abstract Superficial pT1 bladder tumors are characterized by a high risk of recurrence and progression in grade and stage. Few studies provided evidence that loss of adipocyte‐fatty acid binding protein (A‐FABP) expression was associated with bladder cancer progression. A‐FABP is a lipid binding